{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:52Z","timestamp":1793060032494,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcv.2019.08.002","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:37:24Z","timestamp":1564745844000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9644-085X","authenticated-orcid":false,"given":"Sara","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Tim\u00f3teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S\u00e3o","family":"Jos\u00e9 Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8373","authenticated-orcid":false,"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-2131","authenticated-orcid":false,"given":"Hugo","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2019.08.002_bib0005","series-title":"Hepatitis E","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.jcv.2019.08.002_bib0010","series-title":"Hepatitis E | Immunization, Vaccines and Biologicals","author":"World Health Organization","year":"2015"},{"issue":"9835","key":"10.1016\/j.jcv.2019.08.002_bib0015","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcv.2019.08.002_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0033-1338113","article-title":"Zoonotic and foodborne transmission of hepatitis E virus","volume":"33","author":"Meng","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jcv.2019.08.002_bib0025","series-title":"The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: a Systematic Review","author":"World Health Organization","year":"2010"},{"issue":"6","key":"10.1016\/j.jcv.2019.08.002_bib0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1051\/vetres\/2010018","article-title":"Zoonotic hepatitis E: animal reservoirs and emerging risks","volume":"41","author":"Pavio","year":"2010","journal-title":"Vet. Res."},{"issue":"11","key":"10.1016\/j.jcv.2019.08.002_bib0035","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1128\/JCM.42.11.5371-5374.2004","article-title":"Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan","volume":"42","author":"Sonoda","year":"2004","journal-title":"J. Clin. Microbiol."},{"issue":"9381","key":"10.1016\/j.jcv.2019.08.002_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(03)14025-1","article-title":"Zoonotic transmission of hepatitis E virus from deer to human beings","volume":"362","author":"Tei","year":"2003","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jcv.2019.08.002_bib0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.21.20812","article-title":"Transfusion-transmitted hepatitis E in Germany, 2013","volume":"19","author":"Huzly","year":"2014","journal-title":"Euro Surveill."},{"issue":"5","key":"10.1016\/j.jcv.2019.08.002_bib0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood-2013-09-524348","article-title":"Hepatitis E transmission by transfusion of Intercept blood system-treated plasma","volume":"123","author":"Hauser","year":"2014","journal-title":"Blood"},{"issue":"9956","key":"10.1016\/j.jcv.2019.08.002_bib0055","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.jcv.2019.08.002_bib0060","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.2807\/1560-7917.ES.2017.22.26.30561","article-title":"Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015","volume":"22","author":"Aspinall","year":"2017","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jcv.2019.08.002_bib0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2014.11.020","article-title":"Frequent hepatitis E in the Netherlands without traveling or immunosuppression","volume":"62","author":"Koot","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.08.002_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcv.2016.06.010","article-title":"Hepatitis E virus: assessment of the epidemiological situation in humans in Europe, 2014\/15","volume":"82","author":"Adlhoch","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2009.01.005","article-title":"Indigenous hepatitis E virus infection in England: more common than it seems","volume":"44","author":"Ijaz","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"35\u201336","key":"10.1016\/j.jcv.2019.08.002_bib0080","first-page":"577","article-title":"Hepatitis E in Germany\u2013an under-reported infectious disease","volume":"111","author":"Pischke","year":"2014","journal-title":"Arztebl. Int."},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/cid\/cit782","article-title":"Endemic hepatitis e in the Czech Republic","volume":"58","author":"Chalupa","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2019.08.002_bib0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcv.2012.02.015","article-title":"Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation","volume":"54","author":"Abravanel","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.08.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis e virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2019.08.002_bib0100","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.jcv.2019.08.002_bib0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/TP.0000000000002097","article-title":"Toward systematic screening for persistent hepatitis E virus infections in transplant patients","volume":"102","author":"Ankcorn","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jcv.2019.08.002_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2009.141","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe 2009","volume":"45","author":"Ljungman","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jcv.2019.08.002_bib0115","series-title":"The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT","first-page":"23","article-title":"HSCT: how does It work?","author":"Galgano","year":"2018"},{"issue":"9","key":"10.1016\/j.jcv.2019.08.002_bib0120","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1182\/blood.V96.9.3290","article-title":"Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation","volume":"96","author":"Storek","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcv.2019.08.002_bib0125","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3324\/haematol.2011.047696","article-title":"Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Wils","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jcv.2019.08.002_bib0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2004.04.001","article-title":"Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement","volume":"19","author":"Wils","year":"2005","journal-title":"Blood Rev."},{"issue":"9","key":"10.1016\/j.jcv.2019.08.002_bib0135","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/trf.14191","article-title":"Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program: impact of pbm program in hematology","volume":"57","author":"Leahy","year":"2017","journal-title":"Transfusion"},{"issue":"June 2019","key":"10.1016\/j.jcv.2019.08.002_bib0140","article-title":"Implementation of a patient blood management program in hematopoietic stem cell transplantation: PBM in stem cell transplantation","author":"Warner","year":"2019","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jcv.2019.08.002_bib0145","first-page":"152","article-title":"Chronic hepatitis E \u2013 an emerging disease in an immunocompromised host","volume":"6","author":"Singh","year":"2018","journal-title":"Gastroenterol. Rep. (Oxf)"},{"key":"10.1016\/j.jcv.2019.08.002_bib0150","article-title":"Hepatitis E: an underestimated emerging threat","volume":"6","author":"Webb","year":"2019","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2019.08.002_bib0155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3201\/eid1805.111712","article-title":"Hepatitis E virus infection among solid organ transplant recipients, the Netherlands","volume":"18","author":"Pas","year":"2012","journal-title":"Emerging Infect. Dis."},{"issue":"8","key":"10.1016\/j.jcv.2019.08.002_bib0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl."},{"issue":"11","key":"10.1016\/j.jcv.2019.08.002_bib0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J. Epidemiol. Community Health"},{"issue":"5","key":"10.1016\/j.jcv.2019.08.002_bib0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/bjh.15672","article-title":"Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: Incidence and clinical course","volume":"184","author":"Tang","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0180","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/bmt.2016.327","article-title":"Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients","volume":"52","author":"Willemse","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.jcv.2019.08.002_bib0185","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2013-03-492363","article-title":"Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation","volume":"122","author":"Versluis","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcv.2019.08.002_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-3062.2011.00702.x","article-title":"Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?","volume":"14","author":"Koenecke","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.08.002_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2018.07.011","article-title":"Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period","volume":"107","author":"Reekie","year":"2018","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.jcv.2019.08.002_bib0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jmv.21656","article-title":"A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries","volume":"82","author":"Bendall","year":"2010","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jcv.2013.10.010","article-title":"Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients","volume":"58","author":"Pas","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"11","key":"10.1016\/j.jcv.2019.08.002_bib0210","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/jmv.24251","article-title":"Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection","volume":"87","author":"Avellon","year":"2015","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.jcv.2019.08.002_bib0215","doi-asserted-by":"crossref","DOI":"10.3390\/v8080211","article-title":"Hepatitis E Seroprevalence in Europe: A meta-analysis","volume":"8","author":"Hartl","year":"2016","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.jcv.2019.08.002_bib0220","doi-asserted-by":"crossref","first-page":"25711","DOI":"10.3390\/ijms161025711","article-title":"Epidemiology of hepatitis E virus in european countries","volume":"16","author":"Lapa","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jcv.2019.08.002_bib0225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S0950268813001167","article-title":"Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy)","volume":"142","author":"Scotto","year":"2014","journal-title":"Epidemiol. Infect."},{"issue":"12","key":"10.1016\/j.jcv.2019.08.002_bib0230","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3201\/eid1712.110371","article-title":"Hepatitis E virus antibodies in blood donors, France","volume":"17","author":"Mansuy","year":"2011","journal-title":"Emerging Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2019.08.002_bib0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcv.2009.03.006","article-title":"Hepatitis E virus in patients with unexplained hepatitis in Finland","volume":"45","author":"Kantala","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"March 2019","key":"10.1016\/j.jcv.2019.08.002_bib0240","article-title":"Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: The Troms\u00f8 study","author":"Ols\u00f8y","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.jcv.2019.08.002_bib0245","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3201\/eid1810.111756","article-title":"Hepatitis E virus seroprevalence among adults, Germany","volume":"18","author":"Faber","year":"2012","journal-title":"Emerging Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0250","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/eurpub\/ckx213","article-title":"A nationwide serosurvey of hepatitis E virus antibodies in the general population of Portugal","volume":"28","author":"Nascimento","year":"2018","journal-title":"Eur. J. Public Health"},{"issue":"31","key":"10.1016\/j.jcv.2019.08.002_bib0255","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","article-title":"Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012","volume":"18","author":"Slot","year":"2013","journal-title":"Euro Surveill."},{"issue":"5","key":"10.1016\/j.jcv.2019.08.002_bib0260","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12929","article-title":"Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain)","volume":"55","author":"Sauleda","year":"2015","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.jcv.2019.08.002_bib0265","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28436","article-title":"A nationwide survey of hepatitis E viral infection in French blood donors","volume":"63","author":"Mansuy","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jcv.2019.08.002_bib0270","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/MEG.0b013e3282f5195a","article-title":"Autochthonous hepatitis E in Southwest England: Natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease","volume":"20","author":"Dalton","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219301714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219301714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:11:39Z","timestamp":1761361899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219301714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":54,"alternative-id":["S1386653219301714"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.08.002","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}